Does Blood Glucose Control work?

Updated May 2026

Quick Answer

Blood Glucose Control has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Due to the complexity of blood glucose dynamics and the high variability of the physiological structure of diabetic patients, implementing a safe and effective insulin dosage control algorithm to keep the blood glucose of diabetic patients within the normal range (70-180 mg/dL) is currently a challenging task in the field of diabetes treatment.

Key Takeaways

  • 01Due to the complexity of blood glucose dynamics and the high variability of the physiological structure of diabetic patients, implementing a safe and effective insulin dosage control algorithm to keep the blood glucose of diabetic patients within the normal range (70-180 mg/dL) is currently a challenging task in the field of diabetes treatment. [Huang S (2026)]
  • 02Deep reinforcement learning (DRL) has proven its potential in diabetes treatment in previous work, thanks to its strong advantages in solving complex dynamic and uncertain problems. [Huang S (2026)]
  • 03Type 2 diabetes is the most prevalent form of the condition, characterized by hyperglycaemia, insulin resistance, and relative insulin deficiency (ADA) () Research indicates that rigorous metabolic management may postpone or prevent the development of complications associated with diabetes (). [Salman Al-Shami Ali (2025)]
  • 04Data from the Diabetes Control and Complications Trial (DCCT Research Group) show that in individuals with type 1 diabetes, a 10% reduction in glycated hemoglobin (GHb) levels was associated with a 43% decrease in the risk of retinopathy progression (). [Salman Al-Shami Ali (2025)]
The current Migaku evidence database contains 2 reusable source documents for Blood Glucose Control. This answer focuses on strength of evidence and what the studies can or cannot prove. - Due to the complexity of blood glucose dynamics and the high variability of the physiological structure of diabetic patients, implementing a safe and effective insulin dosage control algorithm to keep the blood glucose of diabetic patients within the normal range (70-180 mg/dL) is currently a challenging task in the field of diabetes treatment. [Huang S (2026); evidence level 4] - Deep reinforcement learning (DRL) has proven its potential in diabetes treatment in previous work, thanks to its strong advantages in solving complex dynamic and uncertain problems. [Huang S (2026); evidence level 4] - Type 2 diabetes is the most prevalent form of the condition, characterized by hyperglycaemia, insulin resistance, and relative insulin deficiency (ADA) () Research indicates that rigorous metabolic management may postpone or prevent the development of complications associated with diabetes (). [Salman Al-Shami Ali (2025); evidence level 4] - Data from the Diabetes Control and Complications Trial (DCCT Research Group) show that in individuals with type 1 diabetes, a 10% reduction in glycated hemoglobin (GHb) levels was associated with a 43% decrease in the risk of retinopathy progression (). [Salman Al-Shami Ali (2025); evidence level 4] - Findings from the Gallichan study, further indicated that morbidity associated with diabetes mellitus—as well as the use of healthcare resources for managing diabetic complications—could potentially be reduced by significantly improving blood glucose control (). [Salman Al-Shami Ali (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. A Hybrid Closed-Loop Blood Glucose Control Algorithm with a Safety Limiter Based on Deep Reinforcement Learning and Model Predictive Control.
  2. “Assessment of diabetes management strategies for blood glucose control in Sana’a City General Hospitals”